Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Sleep Disorders in CKD
NCT05240261Phase 1Unknown
- Sponsor
- Assiut University
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of quetiapine in sleep disorder (2 arms), sponsored by Assiut University. Primary endpoints: Change in Blood Pressure Measurement at 3 months, Quality of Life Scale at 3 months and 1 more. Status: unknown.
02
Drugs
quetiapine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT05240261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05240261.